Randomized phase II trial of adjuvant chemotherapy (CBDCA+GEM vs TS1+DTX) for completely resected non-small cell lung cancer
Phase 2
- Conditions
- non-small cell lung cancer
- Registration Number
- JPRN-UMIN000000781
- Lead Sponsor
- Japanese Northern East Area Thoracic Surgery Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
symptomatic interstitial pneumonia multiple lung cancer or other-type cancer within 5 years severe organ failure past history of radiotherapy or chemotherapy pregnant or expecting mother
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 2-year relapse free survival
- Secondary Outcome Measures
Name Time Method toxicity